Skip to main content

Table 2 Subtype frequencies, gender, age and Diagnostic delay

From: Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates

JIA subtype

Number of patients (%)

Gender(M/F)

N/N (%/%)

Age at Dx

Years

Diagnosis Delay

(months ±SD)

Entry

cJADAS 10

(range)

Persistent Oligo

66 (48)

10/56 (15/85)

6 (1–14)

5.4 (3–5.6)

11 (9–15)

Extended Oligo

9 (7)

1/8 (11/89)

4 (2–13)

3.2 (3–5.6)

 

Poly RF + ve

3 (2)

1/2(33/67)

15 (13–16)

5 (4.2–6)

19 (17–22)

Poly RF-ve

32 (23)

12/20 (38/62)

7.5(3–13)

4 (3–5)

19 (17–22)

ERA

10 (7)

3/4(43/57)

9(8–16)

11.4 (6–25)

14 (13–16)

Psoriatic

8 (6)

2/6(25/75)

6 (5–15)

1 (1–5)

13 (12–15)

Systemic

7 (5)

3/4(43/57)

2 (1–6)

1.2 (1–2)

21 (19–24)

Undifferentiated

3 (2)

1/2

8 (6–10)

7.5 (4–9)

12 (11–13)

Total

138 (100)

40/98 (71/29)

   
  1. JIA Juvenile Idiopathic Arthritis, ERA Enthesitis Related Arthritis. CJADAS 10